NexPoint Residential Trust is an apartment REIT focused on Sun Belt markets such as Phoenix, South Florida, Dallas/Fort Worth, and Atlanta. Core FFO growth continued in Q2 2025, although the key driving factor, share repurchases, appears unsustainable in light of rising leverage. Operational performance remains challenging, with no immediate turnaround expected in H2 2025.

BXMT's Q2 2025 results were largely as expected, with minor BV fluctuations and modest core earnings outperformance driven by higher-than-anticipated loan originations. The company shifted to a more aggressive loan origination strategy, signaling a potential stabilization in portfolio size, but credit risk remains elevated with new non-accrual loans. I maintain a risk/performance rating of 4.5, as BXMT is still working through legacy troubled loans and faces ongoing challenges in office and multifamily segments.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the "Class Period"), of the important September 12, 2025 lead plaintiff deadline.

REX American Resources Corporation (NYSE:REX ) Q2 2025 Earnings Call August 27, 2025 11:00 AM ET Company Participants Douglas L. Bruggeman - VP of Finance, CFO & Treasurer Stuart A.

AAL faces margin pressure as high labor costs and weak revenues weigh on the outlook despite second-quarter gains.

UPS hikes import fees as the United States ends duty-free exemptions, but weak volumes, high costs and dividend strain weigh on the stock.

There have been some significant acquisitions in the mid-cap biotech space over the past couple of months. In today's column, I highlight two mid-cap biotech names that should have bright futures on their own, but would make logical buyout candidates: Abivax Société Anonyme and MoonLake Immunotherapeutics. Both have late-stage assets targeting large markets, and both companies should file for their first FDA approvals in 2026.

NEW YORK and MAINZ, GERMANY, AUGUST 27, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA) for use in adults ages 65 years and older, as well as in individuals ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.2

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA) for use in adults ages 65 years and older, as well as in individuals ages 5 through 64 years with at least one underlying condition that puts the.

High-quality oil stocks like Schlumberger, Halliburton, and Devon Energy have seen significant declines but likely bottomed in early April. Oil prices are unlikely to stay depressed, with potential for a substantial move higher by 2026 as market dynamics and political factors shift. Saudi Arabia's need for higher oil prices and anticipated Fed rate cuts should support a rebound in oil prices and sector equities.

SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- On August 20, 2025, investors in James Hardie Industries plc (NYSE: JHX) saw the price of their shares crash $9.79 (-34%) after the company reported its Q1 2026 financial results and revealed problems with its North America business, its largest reporting segment.

AI hype that has helped push U.S. stocks to fresh records this year has driven an explosion in leveraged single stock exchange-traded funds, a universe of speculative products that is likely to be tested by Nvidia's NVDA.O Wednesday earnings.

Buyout firm Apollo Global Management owns more than 80% of the publicly traded insurer.

St. Petersburg, Fla., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Raymond James (NYSE: RJF) recently welcomed financial advisors Stew Flaherty, AIF®, ChFC®, CLU®, CRC®, and Tami Colvin, CFP®, CRC®, to Raymond James Financial Services (RJFS) – the firm's independent advisor channel – according to David Sisemore, Midwest divisional director for RJFS.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Citizens Financial Services (CZFS) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First Financial (FFIN) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Kimco Realty (KIM) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Hancock Whitney (HWC) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does First United (FUNC) have what it takes?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes?